# Merck & Co., Inc. (MRK): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Merck & Co., Inc. (MRK) is 61/100, ranked against 24,000+ stocks in 35 markets (Quality 54, Value 36, Momentum 65, each scored against its sector).

- StockRank: 61/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 54, Value 36, Momentum 65: each a 0-100 percentile within Healthcare.
- Position: #10,436 overall, #1,007 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - General.
- Last close: 140.61 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 30.0M.
- Buybacks, last 180 days: the company bought back USD 4.1B on 2 days.

Source: https://moatmap.ai/stock/MRK
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker